Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS

Showing 15 posts of 1107 posts found.

Doctors highlight NHS data concerns

February 13, 2014
Medical Communications, Sales and Marketing NHS, RGCP, UK, care data, doctors

Senior doctors have voiced their worries about the public’s lack of preparedness for the government’s planned roll-out of patient data …

News
roche image

Kadcyla launches in UK

February 13, 2014
Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast

 Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …

News

NHS England savings ‘not used wisely’

February 12, 2014
Sales and Marketing England, NHS, QIPP, Simon Stevens, health select

A group of influential MPs has raised serious concerns over what the £10 billion worth of NHS England savings made …

News
NICE image

NICE: ‘Use more statins’

February 12, 2014
Sales and Marketing NHS, NICE, baker, cvd, statins

NICE has decided more NHS patients ought to be considered at risk of cardiovascular disease (CVD) – and therefore advises …

News

Concerns over big pharma links to NHS policy

February 12, 2014
Research and Development, Sales and Marketing England, NHS, jmc, pharma, shca

NHS England has reportedly commissioned a big pharma lobby group to create an influential report, stoking fears that the five-year …

News

Three new entries to Cancer Drugs Fund

February 5, 2014
Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo

Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …

News
sir michael parkinson image

Sir Michael Parkinson criticises NICE

February 4, 2014
Medical Communications, Sales and Marketing Astellas, NHS, NICE, Xtandi, parkinson, prostate

TV host Sir Michael Parkinson has told NICE that it must lift the restrictions imposed on Astellas’ new prostate cancer …

News
Roche image

Roche: NICE guidance ‘perverse’

February 4, 2014
Sales and Marketing NHS, NICE, NSCLC, Roche, Tarceva

Roche has poured scorn on NICE’s ‘perverse’ recommendation that its EGFR-TK inhibitor Tarceva should no longer be given to NHS …

News
CDF image

Cancer Drugs Fund: assessing a difficult legacy

February 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty

England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …

Feature

NICE looks at Xtandi again

January 28, 2014
Sales and Marketing Astellas, NHS, NICE, Xtandi

NICE has announced it is to consult again on its decision to recommend Astellas Pharma’s prostate cancer drug Xtandi after …

News
doh image

NICE rejects ‘benefit’ test

January 28, 2014
Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …

News
nhs_parliament_2

NHS reform: did the government get it right?

January 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DH, Hunt, Lansley, NHS, atkins, reform, reforms

Some nine months after the coalition government’s controversial health reforms came in, have they been a success? And how are …

Feature
NHS image

Elderly denied cancer treatment on NHS

January 24, 2014
Sales and Marketing Cancer, Macmillan, NCIN, NHS, elderly

A UK charity is warning the NHS not to write off older cancer patients as ‘too old’ for treatment. With …

News

Mail backs down over NICE ‘champagne perks’ attack

January 24, 2014
Medical Communications, Sales and Marketing Daily Mail, NHS, NICE, UK, spending

The Daily Mail newspaper has backed down on an article it published earlier this month, which alleged that staff at …

News

NHS consults on loosening controls for Viagra

January 23, 2014
Sales and Marketing DH, ED, NHS, Pfizer, Sildenafil, viagra

The Department of Health is looking to make cheaper generic versions of Pfizer’s Viagra more widely available to patients with …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026